The immunochemistry products market was valued at USD 2.4 billion in 2025, is projected to reach USD 5.3 billion by 2036 and is forecast to register a 7.5% CAGR between 2026 and 2036. In 2026, immunochemistry analyzer holds 61.8% within the product type segment and hospitals and clinics represent 47.3% of the end user category.